Breaking News Instant updates and real-time market news.

CELG

Celgene

$122.36

1.75 (1.45%)

14:25
06/18/17
06/18
14:25
06/18/17
14:25

Celgene reports updated data from 'MAGNIFY' study of Revlimid

Celgene announced results from an interim analysis of MAGNIFY, a phase IIIb study of REVLIMID plus rituximab combination therapy in patients with relapsed or refractory marginal zone lymphoma. Results were presented at the International Conference on Malignant Lymphoma, and expanded upon data presented earlier in the month at the American Society of Clinical Oncology meeting. At ASCO, interim data were presented from an analysis of a subset of patients from the MAGNIFY study with relapsed or refractory FL with early relapse and double-refractory disease. Data being presented at ICML in a separate analysis focused on patients with MZL, including nodal MZL, splenic MZL and mucosa-associated lymphoid tissue lymphoma. At a median follow-up of 13.8 months from initiation of therapy with the R2 combination, evaluable patients with MZL achieved an ORR of 66% with a CR/CRu rate of 44%. Evaluable nodal MZL patients had an ORR of 57% with a CR/CRu rate of 57%. Evaluable splenic MZL patients had an ORR of 63% with a CR of 25%; and evaluable MALT patients had an ORR of 80% with a CR/CRu rate of 40%. Median duration of response was not reached for any group. The most common grade 3 or 4 adverse events observed in patients with MZL were neutropenia, thrombocytopenia and leukopenia.

  • 22

    Jun

CELG Celgene
$122.36

1.75 (1.45%)

06/16/17
06/16/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Teva (TEVA) upgraded to Neutral from Underperform at Mizuho with analyst Irina Koffler citing reduced near-term risk of a Mylan's (MYL) generic Copaxone approval, potential asset sale announcements, and encouraging May subscription trends. 2. Brookfield Infrastructure (BIP) upgraded to Outperform from Neutral at Credit Suisse with analyst Andrew Kuske saying the potential inclusion of Brookfield Infrastructure into the S&P Index is likely to have a "meaningful impact" on demand around the third quarter index revision. 3. Celgene (CELG) upgraded to Outperform from Market Perform at Leerink with analyst Geoffrey Porges saying he views Celgene's valuation as "discounted." 4. Regency Centers (REG) upgraded to Buy from Hold at Jefferies with analyst George Hoglund saying he believes the recent pullback in the shares creates an attractive entry point. 5. Nanometrics (NANO) upgraded to Buy from Hold at Stifel with analyst Patrick Ho citing valuation, along with his belief that wafer lab equipment spending will be strong next year and that the "elevated spending" level may be sustainable. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/16/17
LEER
06/16/17
UPGRADE
Target $150
LEER
Outperform
Leerink upgrades Celgene to Outperform on 'discounted valuation'
Leerink analyst Geoffrey Porges upgraded Celgene to Outperform from Market Perform and raised his price target for the shares to $150 from $146. The biopharmaceutical company closed yesterday down 43c to $120.61. The analyst, who points out his revenue estimates for 2017-2019 are above the consensus, views Celgene's valuation as "discounted." The analyst expects the company's operating results to rebound in Q2 and stock's multiple to recover in Q3 "towards a more growth-appropriate range." He also anticipates "significant upward revisions" to consensus expectations in Q3.
06/16/17
LEER
06/16/17
UPGRADE
Target $150
LEER
Outperform
Celgene upgraded to Outperform from Market Perform at Leerink
Leerink analyst Geoffrey Porges upgraded Celgene to Outperform and raised his price target for the shares to $150 from $146.
06/13/17
06/13/17
NO CHANGE
Target $63

Outperform
FBR keeps $61 target on Acceleron after dalantercept failure
FBR Capital analyst Ed White says that while the dalantercept failed Phase II study is "disappointing," his focus remains on luspatercept, which is being studied in beta-thalassemia and myelodysplastic syndrome. Celgene (CELG) estimates peak sales potential of over $2B for luspatercept, which could translate into more than $400M in revenue for Acceleron Pharma (XLRN), White tells investors in a research note. He thinks luspatercept could be brought to market by 2019. White's price target for Acceleron remains $63 as he had only a 15% probability of approval and a low revenue estimate for dalantercept. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

CELG

Celgene

$102.65

0.93 (0.91%)

14:40
01/22/18
01/22
14:40
01/22/18
14:40
Options
Celgene calls outpace puts 3:1 as shares tick modestly higher »

Celgene calls outpace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

14:40
01/22/18
01/22
14:40
01/22/18
14:40
General news
Treasury Action: yields have reversed the earlier declines »

Treasury Action: yields…

GENC

Gencor Industries

14:30
01/22/18
01/22
14:30
01/22/18
14:30
Hot Stocks
Royce & Associates reports 7.37% passive stake in Gencor Industries »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPL

Buckeye Partners

$56.18

1.155 (2.10%)

14:30
01/22/18
01/22
14:30
01/22/18
14:30
Options
Bullish option flow in Buckeye Partners as shares rally »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 09

    Feb

CLVS

Clovis

$56.76

0.89 (1.59%)

14:25
01/22/18
01/22
14:25
01/22/18
14:25
Options
Clovis call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 08

    Feb

$NSD

NASDAQ Market Internals

14:17
01/22/18
01/22
14:17
01/22/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/22/18
01/22
14:16
01/22/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYBE

Cyberoptics

$17.15

0.45 (2.69%)

14:05
01/22/18
01/22
14:05
01/22/18
14:05
Hot Stocks
Royce & Associates reports 9.64% passive stake in Cyberoptics »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$34.31

0.81 (2.42%)

14:05
01/22/18
01/22
14:05
01/22/18
14:05
Options
FMC Technologies call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CTB

Cooper Tire

$39.65

-0.7 (-1.73%)

14:04
01/22/18
01/22
14:04
01/22/18
14:04
Hot Stocks
Royce & Associates reports 5.14% passive stake in Cooper Tire »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTG

Computer Task Group

$5.09

0.12 (2.41%)

14:02
01/22/18
01/22
14:02
01/22/18
14:02
Hot Stocks
Breaking Hot Stocks news story on Computer Task Group »

Royce & Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$85.88

18.185 (26.87%)

14:01
01/22/18
01/22
14:01
01/22/18
14:01
Downgrade
Juno Therapeutics rating change  »

Juno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INGR

Ingredion

$140.05

2.92 (2.13%)

13:47
01/22/18
01/22
13:47
01/22/18
13:47
Hot Stocks
Ingredion promotes Anthony DeLio to SVP, corporate strategy »

Ingredion Incorporated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

ADSK

Autodesk

$115.29

2.74 (2.43%)

13:45
01/22/18
01/22
13:45
01/22/18
13:45
Options
Autodesk call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOB

Globant

$47.41

-0.86 (-1.78%)

13:44
01/22/18
01/22
13:44
01/22/18
13:44
Hot Stocks
Breaking Hot Stocks news story on Globant »

JP Morgan Chase reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

NWSA

News Corp.

$17.22

0.21 (1.23%)

, NWS

News Corp

$17.55

0.15 (0.86%)

13:39
01/22/18
01/22
13:39
01/22/18
13:39
Hot Stocks
News Corp. chairman Murdoch makes case for carriage fee for trusted publishers »

News Corp. (NWSA) issued…

NWSA

News Corp.

$17.22

0.21 (1.23%)

NWS

News Corp

$17.55

0.15 (0.86%)

FB

Facebook

$181.29

1.49 (0.83%)

GOOG

Alphabet

$1,137.51

7.72 (0.68%)

GOOGL

Alphabet Class A

$1,143.50

7.53 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

  • 18

    Mar

W

Wayfair

$90.98

3.135 (3.57%)

13:35
01/22/18
01/22
13:35
01/22/18
13:35
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

13:35
01/22/18
01/22
13:35
01/22/18
13:35
General news
Treasury Action: yields rebounded towards highs »

Treasury Action: yields…

JNJ

Johnson & Johnson

$147.76

0.4 (0.27%)

, PG

Procter & Gamble

$91.66

0.59 (0.65%)

13:33
01/22/18
01/22
13:33
01/22/18
13:33
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JNJ

Johnson & Johnson

$147.76

0.4 (0.27%)

PG

Procter & Gamble

$91.66

0.59 (0.65%)

VZ

Verizon

$52.87

0.955 (1.84%)

KMB

Kimberly-Clark

$116.54

1.0536 (0.91%)

TRV

Travelers

$137.87

0.02 (0.01%)

FITB

Fifth Third

$32.50

0.33 (1.03%)

HBAN

Huntington Bancshares

$15.81

0.3 (1.93%)

WAT

Waters

$214.03

3.31 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 06

    Feb

  • 13

    Feb

  • 16

    Feb

  • 08

    Mar

NFLX

Netflix

$220.46

0.13 (0.06%)

, AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

13:32
01/22/18
01/22
13:32
01/22/18
13:32
Earnings
Notable companies reporting after market close »

Notable companies…

NFLX

Netflix

$220.46

0.13 (0.06%)

AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

RMD

ResMed

$88.10

-0.58 (-0.65%)

STLD

Steel Dynamics

$46.42

0.16 (0.35%)

ZION

Zions Bancorp

$53.73

0.87 (1.65%)

BRO

Brown & Brown

$52.13

-0.375 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 30

    Jan

  • 16

    Feb

JEC

Jacobs Engineering

$70.29

0.34 (0.49%)

, VMC

Vulcan Materials

$133.37

-1.66 (-1.23%)

13:29
01/22/18
01/22
13:29
01/22/18
13:29
Periodicals
Axios obtains draft of White House infrastructure plan »

Jonathan Swan of Axios…

JEC

Jacobs Engineering

$70.29

0.34 (0.49%)

VMC

Vulcan Materials

$133.37

-1.66 (-1.23%)

PWR

Quanta Services

$39.03

0.04 (0.10%)

EXP

Eagle Materials

$116.71

-0.3099 (-0.26%)

FLR

Fluor

$61.14

0.71 (1.17%)

USCR

U.S. Concrete

$78.90

0.65 (0.83%)

ACM

Aecom

$39.12

-0.09 (-0.23%)

CBI

CB&I

$19.16

0.19 (1.00%)

GVA

Granite Construction

$67.14

-0.5 (-0.74%)

CAT

Caterpillar

$170.34

-0.07 (-0.04%)

MLM

Martin Marietta

$226.08

-0.9 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 31

    Jan

  • 06

    Feb

  • 07

    Feb

  • 20

    Feb

  • 14

    Mar

FTR

Frontier Communications

$7.77

0.56 (7.77%)

13:25
01/22/18
01/22
13:25
01/22/18
13:25
Options
Frontier Communications call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

FE

FirstEnergy

$33.24

3.835 (13.04%)

13:25
01/22/18
01/22
13:25
01/22/18
13:25
Conference/Events
FirstEnergy participates in a webcast with Wolfe Research »

Utilities Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

SANM

Sanmina

$35.45

0.5 (1.43%)

, FNSR

Finisar

$20.68

0.26 (1.27%)

13:22
01/22/18
01/22
13:22
01/22/18
13:22
Hot Stocks
Optical equipment makers fall after Sanmina pre-announcement »

Shares of tech companies…

SANM

Sanmina

$35.45

0.5 (1.43%)

FNSR

Finisar

$20.68

0.26 (1.27%)

OCLR

Oclaro

$6.77

0.06 (0.89%)

LITE

Lumentum

$48.85

-2.85 (-5.51%)

VIAV

Viavi

$8.80

-0.14 (-1.57%)

CIEN

Ciena

$21.83

-0.02 (-0.09%)

AAOI

Applied Optoelectronics

$35.03

2.24 (6.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

  • 01

    Feb

  • 05

    Feb

  • 06

    Feb

  • 06

    Feb

  • 21

    Feb

SAP

SAP

$112.46

-0.7357 (-0.65%)

13:20
01/22/18
01/22
13:20
01/22/18
13:20
Hot Stocks
SAP acquires collaborative bot platform Recast AI, details undisclosed »

SAP acquires Recast.AI.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.